Korean J Gastroenterol.  2021 Apr;77(4):160-163. 10.4166/kjg.2021.403.

How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease

Affiliations
  • 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea

Abstract

Patients with inflammatory bowel disease (IBD) are generally considered to be more vulnerable to coronavirus disease 2019 (COVID-19). In addition, there are many concerns about the risk of severe COVID-19 infection in patients with IBD. Because the uncertainty of COVID-19 can cause confusions for patients with chronic diseases, physicians should be able to provide adequate advice for optimal treatment for patients with IBD. As the COVID-19 pandemic continues, current knowledge of COVID-19 is changing based on numerous empirical guidance and clinical data being updated daily. Based on the latest evidence, we will discuss the appropriate strategy and management of patients with IBD in the era of COVID-19.

Keyword

COVID-19; Pandemics; Inflammatory bowel diseases
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error